ApprovalTrail

Drug · DIN 02248302

MULTIHANCE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since October 28, 2004; first marketed October 28, 2004.
Drug Identification Number (DIN)
02248302
Company (DIN owner)
Bracco Imaging CanadaVille D'Anjou, Quebec, Canada
Schedule
Ethical
Dosage form
Solution
Route
Intravenous
Therapeutic class (ATC)
Gadobenic acid V08CA08
Class
Human
Record last updated
June 26, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
GADOBENATE DIMEGLUMINE529 MGML

Notices of Compliance

Health Canada approvals that name this DIN.